Omnia Methodology Specifies Rare Hairy Cell Leukemia Variant and Uncovers Unsuspected AML
Precipio’s Omnia™ Methodology Uncovers Rare Patient Condition From Early Incidental Finding
High-resolution melting assay for rapid, simultaneous detection of JAK2, MPL and CALR variants
Omnia™ Methodology Enables Rapid and Cost Effective Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy
Precipio’s Omnia™ Methodology Identifies Mixed Phenotype Patient with Aggressive MDS Transformation and MPN on Peripheral Blood Sample
Single BCR/ABL1 Fusion Isoform Testing Based on Prior Results Proven Insufficient in Monitoring CML Patient Due to Mutation Co-Expression
Panel-Based Molecular Profiling Finds CALR Mutation in Patient with Persistent MPN and History of JAK2 Mutation
(AMP 2022 Poster): High-Resolution Melting Assay For Rapid Simultaneous Detection Of JAK2, MPL And CALR Variants…
Panel Approach to Molecular Testing for Suspected MPN Patient Reveals Dual Mutation, Driving Greater Care Insight
Myelodysplastic Syndrome Ruled Out For T-Cell
Yale Pathologist Identifies an Unsuspected Metastatic Carcinoma
Precipio Dermatopathology Academic Expert from Yale Provides Consult that Prevents Unnecessary Invasive Surgery
Precipio Soft Tissue Expert from Yale Identifies Malignancy Initially Misdiagnosed as Benign
Yale Expert Identifies Myelodysplastic Syndrome Initially Misdiagnosed as B-Cell Lymphoma
Yale Gastrointestinal Expert Identifies Malignancy Initially Misdiagnosed as Benign
Precipio’s RevCI™ Procedure Delivers Conclusive Lymphoma Diagnosis
Proprietary IV-Cell Culture Media Enabled the Diagnosis of Acute Leukemia
No products in the cart.
Return to shop
Username or email address *
Password *
Remember me Log in
Lost your password?